EVA Pharma is the global healthcare organisation that focuses on local unmet medical needs, by research, innovation and science so that we can all fight for health and wellbeing as a human right.
With a legacy of 106 years in the development of medicines and healthcare solutions, EVA Pharma is one of the fastest-growing healthcare companies in the Middle East and Africa, operating in more than 40 countries worldwide.
Strategic Divisions:
Innovative Products – Branded Generics – Non-branded Generics – API Synthesis – Animal Health – Food Supplements – Partnerships.
Manufacturing Capacities:
With a 5,000-strong team of professionals. The company produces more than one million healthcare products daily at its state-of-the-art manufacturing facilities, which are equipped with cutting-edge technology, are internationally recognized for innovation, and have been approved by multiple regulatory agencies.
EVA is following an ambitious growth strategy, EVA has 3 well-established internationally accredited facilities, including the largest R&D facility, the only immunosuppressant manufacturing facility in the MENA region and currently localizing its operations in Saudi Arabia by establishing a manufacturing facility with the highest global standards in the Kingdom.
The company’s product portfolio focuses on pressing, yet unmet, disease areas, such as diabetes and cardiovascular diseases, oncology, neuroscience, ophthalmology, anti-infectives, bone and pain, hepatology, and reproductive health, to meet both local and international demand.